Notably, PAX7 has recently been implicated in maintaining cancer stemness by activating Wnt/β‐catenin and Notch pathways, thereby enriching chemotherapy‐resistant subpopulations in triple‐negative breast cancer. Here, PAX7 is linked to cancer.